A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children’s Oncology Group AREN0321 study
dc.contributor.author | Geller, James I. | |
dc.contributor.author | Cost, Nicholas G. | |
dc.contributor.author | Chi, Yueh‐yun | |
dc.contributor.author | Tornwall, Brett | |
dc.contributor.author | Cajaiba, Mariana | |
dc.contributor.author | Perlman, Elizabeth J. | |
dc.contributor.author | Kim, Yeonil | |
dc.contributor.author | Mullen, Elizabeth A. | |
dc.contributor.author | Glick, Richard D. | |
dc.contributor.author | Khanna, Geetika | |
dc.contributor.author | Daw, Najat C. | |
dc.contributor.author | Ehrlich, Peter | |
dc.contributor.author | Fernandez, Conrad V. | |
dc.contributor.author | Dome, Jeffrey S. | |
dc.date.accessioned | 2020-12-02T14:41:50Z | |
dc.date.available | WITHHELD_13_MONTHS | |
dc.date.available | 2020-12-02T14:41:50Z | |
dc.date.issued | 2020-12-01 | |
dc.identifier.citation | Geller, James I.; Cost, Nicholas G.; Chi, Yueh‐yun ; Tornwall, Brett; Cajaiba, Mariana; Perlman, Elizabeth J.; Kim, Yeonil; Mullen, Elizabeth A.; Glick, Richard D.; Khanna, Geetika; Daw, Najat C.; Ehrlich, Peter; Fernandez, Conrad V.; Dome, Jeffrey S. (2020). "A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children’s Oncology Group AREN0321 study." Cancer 126(23): 5156-5164. | |
dc.identifier.issn | 0008-543X | |
dc.identifier.issn | 1097-0142 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/163640 | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.subject.other | adjuvant therapy | |
dc.subject.other | nephrectomy | |
dc.subject.other | pediatric renal cell carcinoma | |
dc.subject.other | renal medullary carcinoma | |
dc.subject.other | translocation renal cell carcinoma | |
dc.title | A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children’s Oncology Group AREN0321 study | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Public Health | |
dc.subject.hlbsecondlevel | Oncology and Hematology | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/163640/2/cncr33173.pdf | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/163640/1/cncr33173_am.pdf | en_US |
dc.identifier.doi | 10.1002/cncr.33173 | |
dc.identifier.source | Cancer | |
dc.identifier.citedreference | Wedekind MF, Ranalli M, Shah N. Clinical efficacy of cabozantinib in two pediatric patients with recurrent renal cell carcinoma. Pediatr Blood Cancer. 2017; 64. doi: 10.1002/pbc.26586 | |
dc.identifier.citedreference | de Pasquale MD, Castellano A, de Sio L, et al. Bevacizumab in pediatric patients: how safe is it? Anticancer Res. 2011; 31: 3953 - 3957. | |
dc.identifier.citedreference | Walsh A, Kelly DR, Vaid YN, Hilliard LM, Friedman GK. Complete response to carboplatin, gemcitabine, and paclitaxel in a patient with advanced metastatic renal medullary carcinoma. Pediatr Blood Cancer. 2010; 55: 1217 - 1220. | |
dc.identifier.citedreference | Hakimi AA, Koi PT, Milhoua PM, et al. Renal medullary carcinoma: the Bronx experience. Urology. 2007; 70: 878 - 882. | |
dc.identifier.citedreference | Rais- Bahrami S, Drabick JJ, De Marzo AM, et al. Xp11 translocation renal cell carcinoma: delayed but massive and lethal metastases of a chemotherapy- associated secondary malignancy. Urology. 2007; 70: 178.e3 - 178.e178006. | |
dc.identifier.citedreference | Jimenez I, Brisse HJ, Freneaux P, et al. Pediatric patient with renal cell carcinoma treated by successive antiangiogenics drugs: a case report and review of the literature. J Pediatr Hematol Oncol. 2017; 39: e279 - e284. | |
dc.identifier.citedreference | Chowdhury T, Prichard- Jones K, Sebire NJ, et al. Persistent complete response after single- agent sunitinib treatment in a case of TFE translocation positive relapsed metastatic pediatric renal cell carcinoma. J Pediatr Hematol Oncol. 2013; 35: e1 - e3. | |
dc.identifier.citedreference | Indolfi P, Spreafico F, Collini P, et al. Metastatic renal cell carcinoma in children and adolescents: a 30- year unsuccessful story. J Pediatr Hematol Oncol. 2012; 34: e277 - e281. | |
dc.identifier.citedreference | Parikh J, Coleman T, Messias N, Brown J. Temsirolimus in the treatment of renal cell carcinoma associated with Xp11.2 translocation/TFE gene fusion proteins: a case report and review of literature. Rare Tumors. 2009; 1: e53. | |
dc.identifier.citedreference | Sausville JE, Hernandez DJ, Argani P, Gearhart JP. Pediatric renal cell carcinoma. J Pediatr Urol. 2009; 5: 308 - 314. | |
dc.identifier.citedreference | Spreafico F, Collini P, Terenziani M, Marchiano A, Piva L. Renal cell carcinoma in children and adolescents. Expert Rev Anticancer Ther. 2010; 10: 1967 - 1978. | |
dc.identifier.citedreference | Geller JI, Dome JS. Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinoma. Cancer. 2004; 101: 1575 - 1583. | |
dc.identifier.citedreference | Geller JI, Argani P, Adeniran A, et al. Translocation renal cell carcinoma: lack of negative impact due to lymph node spread. Cancer. 2008; 112: 1607 - 1616. | |
dc.identifier.citedreference | Pantuck AJ, Zisman A, Dorey F, et al. Renal cell carcinoma with retroperitoneal lymph nodes. Impact on survival and benefits of immunotherapy. Cancer. 2003; 97: 2995 - 3002. | |
dc.identifier.citedreference | Cajaiba MM, Dyer LM, Geller JI, et al. The classification of pediatric and young adult renal cell carcinomas registered on the Children’s Oncology Group (COG) protocol AREN03B2 after focused genetic testing. Cancer. 2018; 124: 3381 - 3389. | |
dc.identifier.citedreference | Indolfi P, Bisogno G, Cecchetto G, et al. Local lymph node involvement in pediatric renal cell carcinoma: a report from the Italian TREP project. Pediatr Blood Cancer. 2008; 51: 475 - 478. | |
dc.identifier.citedreference | Geller JI, Ehrlich PF, Cost NG, et al. Characterization of adolescent and pediatric renal cell carcinoma: a report from the Children’s Oncology Group study AREN03B2. Cancer. 2015; 121: 2457 - 2464. | |
dc.identifier.citedreference | Malouf GG, Camparo P, Oudard S, et al. Targeted agents in metastatic Xp11 translocation/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network. Ann Oncol. 2010; 21: 1834 - 1838. | |
dc.identifier.citedreference | Selle B, Furtwangler R, Graf N, Kaatsch P, Bruder E, Leuschner I. Population- based study of renal cell carcinoma in children in Germany, 1980- 2005: more frequently localized tumors and underlying disorders compared with adult counterparts. Cancer. 2006; 107: 2906 - 2914. | |
dc.identifier.citedreference | Ambalavanan M, Geller JI. Treatment of advanced pediatric renal cell carcinoma. Pediatr Blood Cancer. 2019; 66: e27766. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.